PNC Financial Services Group
MIST icon

PNC Financial Services Group’s Milestone Pharmaceuticals MIST Stock Holding History

PNC Financial Services Group’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.42K Hold
2,800
– – ﹤0.01% 4766
2026
Q2 		$3.75K Buy
2,800
+1,800
+180% +$2.88K ﹤0.01% 4491
2026
Q1 		$1.19K Buy
+1,000
New +$1.75K ﹤0.01% 4714
2023
Q1 		– Sell
-137
Closed -$543 – 4771
2022
Q4 		$543 Hold
137
– – ﹤0.01% 4517
2022
Q3 		$1K Buy
+137
New +$1.04K ﹤0.01% 4334

Other funds holding MIST

Pavaki Capital Management
Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
RVW Wealth
RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return
Pinnacle Wealth Planning Services
Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return
October Effect
October Effect Virginia Beach, Virginia $98.3M AUM 66.25% 1-Year Est. Return
Welch & Forbes
Welch & Forbes Boston, Massachusetts $8.34B AUM 13.98% 1-Year Est. Return
Stephenson & Company
Stephenson & Company San Clemente, California $220M AUM 8.29% 1-Year Est. Return

PNC Financial Services Group's MIST Position: Q3 2026 in Review

PNC Financial Services Group held its Milestone Pharmaceuticals (MIST) position steady in Q3 2026 at 2,800 shares worth $2.42K. The position accounts for ﹤0.01% of the portfolio, ranked #4766.

PNC Financial Services Group first reported a position in MIST in Q3 2022 and has held it in 5 quarters since. The position peaked at $3.75K in Q2 2026. 25 funds tracked by Wall St. Rank hold MIST as of Q3 2026.

  • PNC Financial Services Group held 2,800 shares of Milestone Pharmaceuticals worth $2.42K as of Q3 2026.
  • PNC Financial Services Group left its Milestone Pharmaceuticals share count unchanged in Q3 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4766 holding.
  • PNC Financial Services Group first reported a position in Milestone Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
  • PNC Financial Services Group's Milestone Pharmaceuticals position peaked at $3.75K in Q2 2026.
  • 25 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.